📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Neuropathic Pain Companies

Neuropathic pain companies are organizations that specialize in the research, development, and distribution of pharmaceuticals, medical devices, and treatments aimed at alleviating neuropathic pain. Neuropathic pain is a type of chronic pain resulting from damage or dysfunction of the nervous system. These companies play a crucial role in improving the quality of life for individuals suffering from this debilitating condition.

Neurorehabilitation Devices key companies*Disclaimer: List of key companies in no particular orderLatest Neuropathic pain Companies Update

October 2023: Anglo-French Drugs & Industries, located in India, introduced the AFD-NP as a novel medication for neuropathic pain. It is recommended to use this combination of Nortriptyline and Pregabalin to treat moderate to severe Neuropathic Pain. The Drug Control Department has approved this product. The two chemicals that make up AFD-NP are Nortriptyline 10 mg and Pregabalin 75 mg. Neuropathy patients struggle to fall asleep due to the excruciating pain and suffering they endure. Furthermore, the pain is chronic, which means that it persists for a long time. Nortriptyline has been demonstrated to greatly lessen neuropathic pain and to aid in extending sleep duration. It is quite helpful in cases of mild to severe neuropathy due to its feature. In addition, compared to gabapentin, pregabalin dramatically lowers the number of days with discomfort.

January 2023: Abbott, a global leader, announced that the FDA has given the go-ahead for their ProclaimTM XR spinal cord stimulation (SCS) system to treat severe diabetic peripheral neuropathy (DPN), a crippling consequence of diabetes. Patients with DPN in need of alternatives to conventional treatment modalities, such as oral medicine, may find relief with the Proclaim XR SCS system. Abbott's NeuroSphereTM Virtual Clinic, a linked care app that allows users to contact with a doctor and obtain treatment changes remotely, will be available to those who receive therapy from the Proclaim XR SCS system. Abbott is dedicated to developing life-changing solutions, including as diagnostics, nutritionals, medications, and medical devices like spinal cord stimulation, to help improve the lives of people with diabetes.

List of Neuropathic pain Key companies in the market

  • Sanofi

  • Abbott

  • Astellas

  • Pfizer

  • Eli Lily

  • Johnson and Johnson

  • AstraZeneca

  • GSK

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.